Business · 06/12/1994Updated: 10/18/2026 · 1 min read
FDA Releases Background Documents on OTC Pediculicide Drug Products
Summary
The Food and Drug Administration (FDA) has released background documents regarding its response to two citizen petitions related to the marketing of over-the-counter pediculicide drug products, aiming to inform all interested parties about the issues raised in the petitions.
Original source language: Federal Register — Health and Human ServicesOpen original release →